Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Sándor, Balogh"'
Autor:
Kálmán, Széll, Sándor, Balogh
Publikováno v:
Orvosi hetilap. 163(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eb929936429be1e91d4893a7476e4490
https://pubmed.ncbi.nlm.nih.gov/34986124
https://pubmed.ncbi.nlm.nih.gov/34986124
Autor:
Kálmán Széll, Sándor Balogh
Publikováno v:
Orvosi Hetilap. 163:39-40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56cdf25a9da58b35e4abdfbe673de7fb
https://doi.org/10.1556/650.2022.1m
https://doi.org/10.1556/650.2022.1m
Autor:
Greta Tarlos, Laszlo Jozsef Szentpeteri, Sándor Balogh, Reka Varnai, István Szabó, Attila Sik, Csilla Sipeky
Publikováno v:
The Pharmacogenomics Journal
Pharmacogenomic biomarker availability of Hungarian Summaries of Product Characteristics (SmPC) was assembled and compared with the information in US Food and Drug Administration (FDA) drug labels of the same active substance (July 2019). The level o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4b3a69067bf46a89a912048e7fab2e5
https://doi.org/10.1038/s41397-019-0123-z
https://doi.org/10.1038/s41397-019-0123-z
Autor:
Sándor Balogh
Publikováno v:
Orvosi Hetilap. 160:1057-1063
Abstract: The health care renumeration poses a great challenge for both politicians and policymakers. During the beginning of the 1990s, following the end of communism in Hungary, the reform of health care began with the introduction of the primary h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0318bbfedc99bcb95db6ac90deb7e860
https://doi.org/10.1556/650.2019.31388
https://doi.org/10.1556/650.2019.31388
Autor:
Sándor Balogh, Iván Igaz, Gábor Simonyi, Roland Gasparics, Mihály Medvegy, Ervin Finta, Tamás Ferenci
Publikováno v:
Orvosi Hetilap. 160:343-348
Abstract: Introduction: The most recent European guidelines for the treatment of hypertension suggest the use of renin-angiotensin-aldosterone system antagonists (RAAS inhibitors) and calcium channel blockers (CCBs) or diuretics fixed-dose combinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78c0b88598c8eaa9595458c006a08dbe
https://doi.org/10.1556/650.2019.31355
https://doi.org/10.1556/650.2019.31355
Publikováno v:
Orvosi hetilap. 161(34)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cecfc329b846b53e21ed1383c823728c
https://pubmed.ncbi.nlm.nih.gov/32804673
https://pubmed.ncbi.nlm.nih.gov/32804673
Autor:
Sándor Balogh, Ferenc Hajnal
Publikováno v:
Orvosi Hetilap. 159:1310-1316
Abstract: It is internationally recognized that the best method for practicing general medical care is family medicine, based on the correct relationship between the physician and the patients/families, where the principles of disease prevention and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::724ebc7e0f2ed8d7a047495a4db7516c
https://doi.org/10.1556/650.2018.31074
https://doi.org/10.1556/650.2018.31074
Publikováno v:
Orvosi Hetilap. 159:735-740
Abstract: In the last few decades, proton-pump inhibitors have become the mainstay of the treatment of acid-related disorders. Despite their efficacy, these drugs are not without risks. Recently several articles have been published on their long-term
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::682f62fa130ac620ab59323f36c732ab
https://doi.org/10.1556/650.2018.31057
https://doi.org/10.1556/650.2018.31057
Publikováno v:
Orvosi Hetilap. 158:523-532
Abstract: Introduction: The experiences gained during the H1N1 flu pandemic in 2009/2010 could serve for a better planning and management of later outbreaks. Aim: The EU-sponsored TELL ME project aimed to provide evidence and develop models for impro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f95365bf46efd4e151243c219f1d584
https://doi.org/10.1556/650.2017.30627
https://doi.org/10.1556/650.2017.30627
Publikováno v:
European Heart Journal. 40
Introduction The latest ESC/ESH guidelines recommended fixed dose combinations (FDC) for first therapy in hypertension. Preferred two-drug combinations are a RAS (renin–angiotensin system) blocker with a CCBs (calcium channel blockers) or a diureti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e984e4a866b8593382989dc4125c1c90
https://doi.org/10.1093/eurheartj/ehz745.0952
https://doi.org/10.1093/eurheartj/ehz745.0952